Introduction
Cowden syndrome (CS) was first described in 1963 by Lloyd and Dennis [1] . CS is among a larger group of diseases also known as multiple hamartoma syndrome [2] . It is a rare, autosomal-dominant, multisystemic disorder characterized by diffuse hamartomatous tissue overgrowth and increased risk of breast, thyroid, and endometrial cancers [3, 4] . Approximately 80% of cases seem to arise from germline mutations in the PTEN gene (phosphatase and tensin homologue gene, 10q22-23 locus) gene, which is a tumor suppressor gene [5] . Clinically, germline mutations in PTEN have also been associated with Bannayan-Riley-Ruvalcaba syndrome, Proteus or Proteus-like syndrome, adult Lhermitte-Duclos disease and autism-like disorders [6] . Gicquel et al. [7] reported a possible correlation of CS with retinal angioma and, more recently, Mansoor and Steel [8] described a case report of proliferative retinopathy in CS. We report the case of a young female patient affected by CS, who complained of ocular discomfort and epiphora. She came to our observation for a complete ophthalmological evaluation in order to establish a possible correlation between CS and ocular disease.
Materials and Methods
Our case report describes a 14-year-old female patient. She complained of severe epiphora and photophobia over the last 2 years. The study adhered to the Declaration of Helsinki, receiving written informed consent from the parents of the minor in order to capture images of the patient's eyes. A complete ophthalmological evaluation was performed, including: best-corrected visual acuity (BCVA) in Early Treatment Diabetic Retinopathy Study (ETDRS) letters, and biomicroscopy of anterior and posterior segments.
Her BCVA was 33 ETDRS letters in each eye. Both eyes were normal except for the anterior segment. Slit lamp examination showed diffuse corneal epithelial alterations with tiny fibrosis of the anterior corneal stroma and whitish epithelial dots ( fig. 1a-f ). Schirmer's test with topical anesthesia, and fluorescein and lissamine green dye tests were performed. In order to investigate the microscopy details of the cornea, confocal evaluation was carried out with corneal Z-ring (Confoscan 4, Nidek Technologies, Padua, Italy). The patient underwent confocal examination after local anesthesia with 2 drops of oxybuprocaine hydrochloride 0.4%.
Results
Schirmer's test with topical anesthesia was normal in both eyes, with tear production of more than 15 mm in 5 min ( fig. 1d) [9] ; fluorescein and lissamine green dye tests were negative. Confocal analysis was considered necessary to obtain the objective and microscopically defined image of the cornea. Although the density of keratocyte cells was normal in posterior and intermediate corneal stroma (495.2 and 795.6 cells/mm 2 , respectively), it was reduced in the anterior stroma (300.2 cells/mm 2 ) ( fig. 2 ). Stromal reflectivity was normal in posterior and intermediate layers, and the stromal nerves looked normal as well. However, stromal reflectivity was higher than normal in the anterior stroma and the nervous subbasal nerve plexus was not appreciable. The thickness of the corneal epithelial layer was approximately 30 µm, showing a decrease with respect to the normal value of 50 µm [10] ; also, the regular architecture had disappeared. The Bowman's layer revealed irregular fibrosis ( fig. 2) . A well-ordered epithelial structure from basal cells to superficial cells was not appreciable and enlarged activated epithelial cells, with highly reflective nuclei, were observable, as occurs in inflammatory chronic disease [11] (fig. 2 ).
Discussion
CS is a rare disorder characterized by diffuse and small hamartomas, commonly identified on the skin and in mucous membranes (i.e. mouth and nose), even though it can also affect the intestinal region as well as other areas. Moreover, patients with CS have an increased risk of developing cancer involving the breast, thyroid, and uterus. The difficulty in diagnosing CS does not allow an exact estimate of its prevalence (1:200,000-250,000 persons) and incidence (1:1,000,000) [12] . Nowadays, prevention and early diagnosis of the development of tumors in these patients play an important role. In our report, we described corneal alterations in a young patient affected by CS. Despite the fact that the patient complained of photophobia and showed epithelial corneal alterations similar to the ones caused by a long-lasting eye drop therapy or by the chronic abuse of contact lenses, alterations to the lissamine, fluorescein and Schirmer's tests were not appreciable. Confocal analysis revealed predominance of alterations in the anterior stromal corneal layers, showing an increase of reflectivity, and a totally unstructured architecture in the epithelium layer. Multicentric investigations on a greater number of patients would be necessary to evaluate the possible correlation between CS and corneal changes. The diagnosis of CS exposes the patient to an increased risk of breast cancer (25-50% compared to 12% in the normal population), thyroid cancer (3-10% compared to 1% in the normal population) and uterine cancer (5-10% compared to 2.5% in the normal population) [6] . Once diagnosed, the patient will undergo testing for the prevention of such tumors to ensure early diagnosis. We would like to highlight this particular corneal alteration because it could be useful for early diagnosis of CS if a correlation between these 2 conditions is found in the future. Moreover, when CS is suspected, genetic investigation could reveal important information concerning this possible correlation. 
